Tilray Brands (TLRY -11.56%) stock tumbled 12% through 9:50 a.m. ET after missing analyst sales forecasts in its Friday morning report.
Heading into the news, Wall Street analysts anticipated Tilray would report sales of $216.3 million for its fiscal second quarter of 2025, ended Nov. 30, but Tilray actually collected just $211 million. On the plus side, Tilray beat expectations for earnings. Analysts forecast a $0.01 per share adjusted loss for the quarter, but Tilray says it broke even.
Despite missing on revenue, Tilray boasted its 9% year-over-year growth to $211 million, setting a new record for Q2 revenue. International cannabis sales grew 25%, beverage revenue grew 36%, and wellness revenue grew 13%.
Management further noted that gross profit increased 29%, with growth extending "across all four business segments."
Still, reading between the lines reveals some surprising weaknesses at this Canadian cannabis company. Take growth in international cannabis sales for example. At 25%, that was more than twice as fast as overall revenue growth. Yet, while management didn't emphasize the point, it turns out that total cannabis sales didn't grow at all. They shrank by 1.5%, to $66 million.
For a company whose main claim to fame is that it sells legal marijuana, that's not a good number.
Speaking of numbers, let's also take a closer look at Tilray's earnings number. Breaking even on earnings sounds better than losing money. Still, only Tilray's adjusted earnings broke even; its generally accepted accounting principles (GAAP) results did not. On the bottom line, net earnings for Q2 were a loss of $85 million, and per share, that worked out to a loss of $0.10 -- nearly 50% worse than last year's $0.07 per share Q2 loss.
Long story short, Tilray is still losing money, just like it lost money in each of the last six years, and just like it's expected to keep losing money next year, and the year after that. Until Tilray starts earning a profit, it's hard to call this stock a buy.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。